Arena Pharmaceuticals, Inc. Derivative Liability
Arena Pharmaceuticals, Inc. had Derivative Liability of $4.00 million as of 2014-06-30, per its 10-Q filed 2014-08-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2014-08-06
- 2014-06-30: Derivative Liability $4.00M.
- 2014-03-31: Derivative Liability $5.00M.
- 2013-12-31: Derivative Liability $4.90M; Derivative Liability as first filed $4.89M.
- 2013-09-30: Derivative Liability $4.94M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2014-06-30 | $4.00M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $5.00M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $4.90M 10-Q · filed 2014-08-06 | $4.89M 10-K · filed 2014-03-03 |
| 2013-09-30 | $4.94M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $9.04M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $11.18M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $15.04M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $15.50M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $20.76M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $1.62M 10-K · filed 2013-03-01 |